Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 15, 2019
Total Value: $1.037B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 998,538 | $118M | 11.3% | $65.40 | — | ADR | 04351P101 |
| — | Amarin | 5,208,305 | $108M | 10.4% | $7.81 | — | ADR | 023111206 |
| — | Principia Biopharma | 2,038,208 | $69.3M | 6.7% | $28.92 | — | COMM | 74257L108 |
| NTRA | Natera | 3,100,560 | $63.93M | 6.2% | $9.81 | +59.7% | COMM | 632307104 |
| — | ObsEva SA | 4,749,623 | $60.75M | 5.9% | $13.49 | — | COMM | H5861P103 |
| — | Y-mAbs Therapeutics, Inc | 2,104,278 | $55.15M | 5.3% | $26.56 | — | COMM | 984241109 |
| — | Spark Therapeutics | 481,270 | $54.81M | 5.3% | $66.59 | — | COMM | 84652J103 |
| — | Nucana Biomed Ltd | 2,400,000 | $40.8M | 3.9% | $19.00 | — | Ordinary Shares | GB00BYWYV |
| CHRS | Coherus BioSciences | 2,868,221 | $39.12M | 3.8% | $10.94 | +22.0% | COMM | 19249H103 |
| — | Nucana Biomed Ltd | 2,266,666 | $38.53M | 3.7% | $15.80 | — | ADR | 67022C106 |
| — | Audentes Therapeutics | 933,640 | $36.43M | 3.5% | $30.05 | — | COMM | 05070R104 |
| — | Merus N.V. | 1,961,039 | $28.96M | 2.8% | $18.53 | — | COMM | N5749R100 |
| — | Ishares Nasdaq Biotechnology | 242,000 | $27.05M | 2.6% | — | — | Put | 464287956 |
| — | Kiniksa Pharmaceuticals, Ltd | 922,700 | $16.66M | 1.6% | $17.35 | — | COMM CL A | G5269C101 |
| — | Iterum Therapeutics | 1,726,514 | $13.68M | 1.3% | $10.89 | — | COMM | G6333L101 |
| — | Allergan plc | 88,665 | $12.98M | 1.3% | $146.41 | — | COMM | G0177J108 |
| NVO | Novo Nordisk A/S | 247,734 | $12.96M | 1.2% | $52.31 | — | ADR | 670100205 |
| ABBV | AbbVie Inc | 150,000 | $12.09M | 1.2% | — | — | Call | 00287Y109 |
| ACRS | Aclaris Therapeutics | 1,911,573 | $11.45M | 1.1% | $19.07 | -65.2% | COMM | 00461U105 |
| AZN | AstraZeneca PLC | 261,577 | $10.57M | 1.0% | $38.70 | — | ADR | 046353108 |
| ALNY | Alnylam Pharmaceuticals Inc | 106,616 | $9.964M | 1.0% | $83.64 | 0.0% | COMM | 02043Q107 |
| NBIX | Neurocrine Biosciences Inc | 112,406 | $9.904M | 1.0% | $90.27 | -7.4% | COMM | 64125C109 |
| BIIB | Biogen Inc | 40,000 | $9.455M | 0.9% | — | — | Call | 09062X103 |
| MGNX | MacroGenics Inc | 523,756 | $9.418M | 0.9% | $16.96 | +1.9% | COMM | 556099109 |
| — | Chiasma | 1,630,221 | $8.477M | 0.8% | $1.49 | — | COMM | 16706W102 |
| — | Entasis Therapeutics Holdings Inc. | 1,180,178 | $7.972M | 0.8% | $10.88 | — | COMM | 293614103 |
| FOLD | Amicus Therapeutics Inc | 584,108 | $7.944M | 0.8% | $12.97 | -5.8% | COMM | 03152W109 |
| ANAB | AnaptysBio Inc | 97,948 | $7.155M | 0.7% | $72.60 | -4.9% | COMM | 032724106 |
| — | Dermira Inc | 483,640 | $6.553M | 0.6% | $10.38 | — | COMM | 24983L104 |
| XNCR | Xencor Inc | 209,907 | $6.519M | 0.6% | $36.53 | -8.9% | COMM | 98401F105 |
| HALO | Halozyme Therapeutics Inc | 401,329 | $6.461M | 0.6% | $16.20 | 0.0% | COMM | 40637H109 |
| — | Biohaven Pharmaceutical Holding Company Ltd | 124,952 | $6.432M | 0.6% | $40.61 | — | COMM | G11196105 |
| — | MorphoSys AG | 69,344 | $6.313M | 0.6% | $103.86 | — | COMM | D55040105 |
| — | Blueprint Medicines Corp | 71,866 | $5.753M | 0.6% | $80.05 | — | COMM | 09627Y109 |
| HRTX | Heron Therapeutics Inc | 233,651 | $5.71M | 0.6% | $34.43 | -24.0% | COMM | 427746102 |
| SVRA | Savara Inc | 766,672 | $5.651M | 0.5% | $11.20 | -32.8% | COMM | 805111101 |
| — | Reata Pharmaceuticals Inc | 65,031 | $5.559M | 0.5% | $56.10 | — | COMM | 75615P103 |
| — | Intercept Pharmaceuticals Inc | 44,918 | $5.024M | 0.5% | $100.80 | — | COMM | 45845P108 |
| — | Deciphera Pharmaceuticals Inc | 214,604 | $4.981M | 0.5% | $20.99 | — | COMM | 24344T101 |
| — | Orchard Therapeutics PLC | 276,083 | $4.937M | 0.5% | $16.15 | — | ADR | 68570P101 |
| INCY | Incyte Corp | 53,097 | $4.567M | 0.4% | $64.93 | +25.3% | COMM | 45337C102 |
| — | Kadmon Holdings Inc | 1,671,770 | $4.414M | 0.4% | $3.00 | — | COMM | 48283N106 |
| — | Synlogic Inc. | 574,972 | $4.364M | 0.4% | $9.38 | — | COMM | 87166L100 |
| AKBA | Akebia Therapeutics Inc | 516,761 | $4.232M | 0.4% | $6.86 | 0.0% | COMM | 00972D105 |
| INSM | Insmed Inc | 140,057 | $4.072M | 0.4% | $25.92 | 0.0% | COMM | 457669307 |
| PBYI | Puma Biotechnology Inc | 93,800 | $3.638M | 0.4% | $48.40 | -36.9% | Call | 74587V107 |
| FATE | Fate Therapeutics Inc | 203,742 | $3.581M | 0.3% | $12.98 | +21.6% | COMM | 31189P102 |
| — | GW Pharmaceuticals PLC | 20,000 | $3.371M | 0.3% | $97.40 | — | ADR | 36197T103 |
| — | FibroGen Inc | 59,017 | $3.207M | 0.3% | $46.27 | — | COMM | 31572Q808 |
| — | Foamix Pharmaceuticals Ltd | 832,293 | $3.121M | 0.3% | $5.26 | — | COMM | M46135105 |
| XBIT | XBiotech Inc | 261,391 | $2.881M | 0.3% | $6.99 | 0.0% | COMM | 98400H102 |
| — | Kala Pharmaceuticals Inc | 345,346 | $2.856M | 0.3% | $6.33 | — | COMM | 483119103 |
| TGTX | TG Therapeutics Inc | 351,811 | $2.829M | 0.3% | $5.40 | 0.0% | COMM | 88322Q108 |
| — | FibroGen Inc | 50,000 | $2.718M | 0.3% | — | — | Put | 31572Q958 |
| — | Otonomy Inc | 1,023,865 | $2.694M | 0.3% | $2.86 | — | COMM | 68906L105 |
| GLPG | Galapagos NV | 20,000 | $2.355M | 0.2% | — | — | Put | 36315X101 |
| — | ArQule Inc | 355,725 | $1.704M | 0.2% | $4.79 | — | COMM | 04269E107 |
| — | Clovis Oncology Inc | 66,635 | $1.654M | 0.2% | $17.96 | — | COMM | 189464100 |
| BMRN | Biomarin Pharmaceutical Inc | 18,494 | $1.643M | 0.2% | $95.13 | -2.6% | COMM | 09061G101 |
| SNDX | Syndax Pharmaceuticals Inc | 213,359 | $1.121M | 0.1% | $6.42 | -11.1% | COMM | 87164F105 |
| PDSB | PDS Biotechnology Corporation | 142,635 | $1.055M | 0.1% | $8.36 | 0.0% | COMM | 70465T107 |
| — | Portola Pharmaceuticals Inc | 30,000 | $1.041M | 0.1% | $34.70 | — | COMM | 737010108 |
| APLS | Apellis Pharmaceuticals, Inc | 49,580 | $967K | 0.1% | $19.65 | -20.0% | COMM | 03753U106 |
| RVLPQ | Osmotica Pharmaceuticals PLC | 253,089 | $911K | 0.1% | $8.00 | -8.0% | COMM | G6S41R101 |
| — | Adverum Biotechnologies Inc | 159,237 | $835K | 0.1% | $5.24 | — | COMM | 00773U108 |
| — | ImmunoGen Inc | 150,000 | $406K | 0.0% | $4.80 | — | Call | 45253H101 |
| — | Conatus Pharmaceuticals Inc | 150,000 | $162K | 0.0% | $4.96 | — | Call | 20600T108 |